IRIS
SPAGNUOLO, ROCCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.484
AS - Asia 1.652
EU - Europa 1.270
SA - Sud America 418
OC - Oceania 47
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 5
Totale 5.915
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.379
SG - Singapore 715
IT - Italia 541
BR - Brasile 315
CN - Cina 314
DE - Germania 231
VN - Vietnam 216
GB - Regno Unito 141
IN - India 138
FI - Finlandia 110
CA - Canada 67
NL - Olanda 52
HK - Hong Kong 50
SE - Svezia 50
AR - Argentina 39
AU - Australia 39
BD - Bangladesh 23
ID - Indonesia 22
IR - Iran 22
MX - Messico 22
FR - Francia 19
EC - Ecuador 18
IQ - Iraq 18
KH - Cambogia 18
PL - Polonia 17
RO - Romania 15
MY - Malesia 13
RU - Federazione Russa 13
TR - Turchia 13
CO - Colombia 12
AT - Austria 11
CL - Cile 11
TH - Thailandia 11
ES - Italia 10
JP - Giappone 10
PK - Pakistan 10
KR - Corea 8
NZ - Nuova Zelanda 8
ZA - Sudafrica 8
ET - Etiopia 7
UA - Ucraina 7
VE - Venezuela 7
IE - Irlanda 6
LV - Lettonia 6
MA - Marocco 6
PH - Filippine 6
PY - Paraguay 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
GR - Grecia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
YE - Yemen 5
DK - Danimarca 4
DZ - Algeria 4
JM - Giamaica 4
LT - Lituania 4
NP - Nepal 4
TN - Tunisia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
CY - Cipro 3
DO - Repubblica Dominicana 3
LB - Libano 3
PE - Perù 3
SY - Repubblica araba siriana 3
BY - Bielorussia 2
CU - Cuba 2
EG - Egitto 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
MK - Macedonia 2
NO - Norvegia 2
PT - Portogallo 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LC - Santa Lucia 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
SV - El Salvador 1
Totale 5.913
Salva come PNG Salva come JPEG
Città #
San Jose 408
Ashburn 293
Singapore 291
Chandler 191
Dallas 178
Munich 176
Santa Clara 112
Ho Chi Minh City 95
Bengaluru 94
Milan 92
Hefei 91
Chicago 71
New York 70
Los Angeles 67
London 63
Helsinki 61
Beijing 56
Catanzaro 53
Lawrence 50
Princeton 50
Hong Kong 46
Turku 41
Boardman 40
São Paulo 38
Hanoi 35
San Francisco 35
Rome 32
Council Bluffs 23
Wilmington 23
Edinburgh 22
Denver 20
Orem 20
Montreal 19
Phnom Penh 18
Des Moines 16
Rio de Janeiro 16
Phoenix 15
Sydney 14
Toronto 13
Amsterdam 12
Brooklyn 12
Mexico City 11
Palermo 11
Redwood City 11
Atlanta 10
Boston 10
Chennai 10
Nuremberg 10
Redmond 10
Warsaw 10
Hamilton 9
Houston 9
Biên Hòa 8
Christchurch 8
Miami 8
San Nicola Manfredi 8
Taranto 8
Tokyo 8
Adelaide 7
Bari 7
Brisbane 7
Buffalo 7
Campinas 7
Da Nang 7
Florence 7
Fortaleza 7
Guangzhou 7
Guayaquil 7
Hanover 7
Hải Dương 7
Mumbai 7
Naples 7
Shanghai 7
Turin 7
Washington 7
Belo Horizonte 6
Brasília 6
Campo Bom 6
Hortolândia 6
Jakarta 6
Kingston 6
Norwalk 6
Ottawa 6
Pattaya 6
Perth 6
Riga 6
Seattle 6
Bắc Giang 5
Catania 5
Collegeville 5
Curitiba 5
Delhi 5
Dhaka 5
Goiânia 5
Horia 5
Jyväskylä 5
Manchester 5
Olomouc 5
Provo 5
Sanaa 5
Totale 3.487
Salva come PNG Salva come JPEG
Nome #
BETA-GLUCAN, INOSITOL AND DIGESTIVE ENZYMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH IRRITABLE BOWEL SYNDROME 626
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 309
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 248
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells. 133
Patient Reported Outcomes come strumento infermieristico nella gestione delle Malattie Infiammatorie Croniche Intestinali (MICI): Sintomi Gastrointestinali e Alterazioni Psicosociali. 79
Anti interleukin 12/23 in the treatment of erythema nodosum and Crohn disease: A case report. 78
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 77
Acceptability of endoscopic procedures and patients' willingness to repeat them: a single-centre nursing study of influential factors 76
DIAPHRAGMATIC REHABILITATION IN GASTROOESOPHAGEAL REFLUX DISEASE 76
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 75
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment 75
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 74
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 73
The role of gluten-free diet in nonalcoholic fatty liver disease development 73
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 72
Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study 71
Effects of a Portfolio-Mediterranean Diet and a Mediterranean Diet with or without a Sterol-Enriched Yogurt in Individuals with Hypercholesterolemia 71
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update 69
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 68
L’epatopatia alcolica: dal danno alla terapia 67
COMPARISON BETWEEN DIFFERENT BOWEL PREPARATION REGIMENS FOR COLONOSCOPY: A SINGLE-CENTRE STUDY 67
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 66
OUTCOME OF ARTHRALGIA IN A SUBGROUP OF INFLAMMATORY BOWEL DISEASE PATIENTS WITH ANTI-TNF-ALPHA. A SINGLE CENTRE STUDY 65
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 64
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 63
Nursing-sensitive outcomes in adult inflammatory bowel disease: A systematic review 63
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 61
Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: Results from a multicenter randomized double-blind placebo-controlled gluten challenge 61
Exome-wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated with Fatty Liver Disease 61
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus 59
Impact of Nursing Interventions via Telephone and Email on the Quality of Life of Patients with Inflammatory Bowel Disease: Preliminary Results of a Comparative Observational Study 59
Deregulation of SGK1 in Ulcerative Colitis: a paradoxical relationship between immune cells and colonic epithelial cells 59
C-reactive protein induces tissue factor expression and promotes smooth muscle cells and endothelial cell proliferation 58
Nursing issues in enteral nutrition during prone position in critically ill patients: A systematic review of the literature 58
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 58
Psychometric evaluation of an Italian custom 4-item short form of the PROMIS anxiety item bank in immune-mediated inflammatory diseases: An item response theory analysis 58
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 57
Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases 57
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study 56
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 56
Nursing communication as a tool for patient satisfaction. A single hospital survey 55
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 55
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 54
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes. 54
The role of Neopterin in cardiovascular disease 54
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies 53
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 53
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 53
OBSERVING THE INFLUENCE OF SHAME AND GUILT IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW 52
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay 52
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 51
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. 51
W1173 An In Vivo Study to Evaluate {MLCK} Expression in Patients with Inflammatory Bowel Diseases 50
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 50
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 49
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 49
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 49
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 49
Visualization of Comorbidities in Inflammatory Bowel Diseases through Networks 48
Lived Experiences of Patients With Inflammatory Bowel Disease in Italy: A Phenomenological Investigation 48
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 48
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 47
Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report 47
The effects of stress on gut virome: Implications on infectious disease and systemic disorders 46
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study 46
Surgery for a gastric Dieulafoy's lesion reveals an occult bleeding jejunal diverticulum. A case report. 46
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 46
Effect of excess body weight on the genetic susceptibility to cancer. 45
Pyoderma Gangrenosum and inflammatory bowel disease: a combined medical and surgical approach - case report and literature review 44
HIGH DIAGNOSTIC YIELD OF HISTOLOGICAL ANALYSIS OF EUS FINE-NEEDLE ASPIRATION BIOPSY INCLUDED IN FORMALIN WITHOUT ON-SITE CYTOPATHOLOGIC EXAMINATION. A RETROSPECTIVE STUDY 44
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 44
Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era 42
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 41
Pro-atherothrombotic effects of sigarette smoking in endothelial cells. Protective effects of statins 41
Can dysmetabolic comorbidities carry hepatic fat accumulation in patients with inflammatory bowel diseases? 40
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE study 40
Milk thistle, Sylibum marianum 40
Use of biosimilars in inflammatory bowel disease: A position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 40
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study 40
Esophageal rupture after Heimlich maneuver: a case report and literature review 39
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 38
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 37
Milk Thistle, Silybum marianum 36
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 33
Gastrointestinal symptoms of and psychosocial changes in inflammatory bowel disease: A nursing-led cross-sectional study of patients in clinical remission 33
MBOAT7 in liver and extrahepatic diseases 32
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study 31
Cross talk between liver and adipose tissue: A new role for PNPLA3? 29
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 26
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 25
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 25
Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic Features 20
Functional disorders of the upper digestive tract: epidemiological, clinical and therapeutic aspects 19
A Case of a Neuroendocrine Tumor in a Liver Transplant Patient: Diagnostic and Management Difficulties 17
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study 16
107 Results From the {\textquotedblleft}{GLUTOX}{\textquotedblright} Trial: A Randomised, Double Blind, Placebo Controlled Crossover Study on {\textquotedblleft}Non Celiac Gluten Sensitivity{\textquotedblright} 15
Impact of Endoscopic Band Ligation on Gastric Complications Associated with Portal Hypertension 14
Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative Colitis 13
Upadacitinib’s Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study 11
Th17/treg balance in Inflammatory Bowel Disease: the role of microbial, and genetic regulators in disease modulation 7
Totale 6.068
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 0 13
2021/2022208 7 1 6 41 16 8 9 39 15 35 22 9
2022/2023672 104 52 23 64 56 47 19 73 86 47 64 37
2023/2024552 94 68 49 32 41 94 25 44 22 14 15 54
2024/20251.288 139 41 39 44 94 148 127 77 158 41 144 236
2025/20263.110 168 276 309 414 280 134 365 170 291 194 454 55
Totale 6.085